SYMPHONY BIOSCIENCES
Symphony Biosciences company is in charge of orchestrating the immune response in the fight against solid cancers. Symphony primary target is triple-negative breast cancer, for which the best current treatments are toxic chemotherapies that simply do not work: survival is poor.
SYMPHONY BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2021-01-01
Address:
Los Angeles, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
400 K USD
Similar Organizations
IES Life Sciences
IES Life Sciences examines the human immune system to treat hard-to-diagnose diseases at an early stage.
Insu Health Design
Insu Health Design is a developer of personal-use system for storing medicines
Novasenta
Novasenta develops treatments to transform the lives of patients with cancer.
Rondo Therapeutics
Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.
SHEPHERD Therapeutics
SHEPHERD Therapeutics specializes in finding cure to rare cancers.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Taiga Biotechnologies
Taiga Biotechnologies is a clinical-stage company focused on harnessing the immune system to fight infectious disease and cancer.
Targeted Cancer Therapeutics
Targeted Cancer Therapeutics develops therapies for treating cancer.
Unleash Immuno Oncolytics
Unleashing the immune response to treat cancer.
Investors List
ISS National Lab
ISS National Lab investment in Grant - Symphony Biosciences
MassChallenge
MassChallenge investment in Non Equity Assistance - Symphony Biosciences
SciFounders
SciFounders investment in Pre Seed Round - Symphony Biosciences
More informations about "Symphony Biosciences"
Symphony Biosciences Company Profile 2024: Valuation, Funding ...
Symphony Biosciences General Information Description. Developer of cancer drugs designed to help treat solid tumors. The company focuses on treating cancer diseases using biomaterials, …See details»
Symphony Biosciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Symphony Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, and 1 literature.See details»
Symphony Biosciences - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Feb 12, 2024: ... Symphony …See details»
Q&A: Symphony founder's immunotherapy sponges …
Feb 16, 2024 Majedi is the CEO of Symphony Biosciences, a startup built around SymphNode, the immunotherapy device she invented. Her company is one of two new recipients of the Technology in Space Prize, an ...See details»
Tiny implantable device designed by UCLA scientists …
Jan 4, 2023 The team aims to make SymphNode available to treat human cancers in the future by licensing the technology to Symphony Biosciences, a company based at the California NanoSystems Institute’s Magnify startup …See details»
Symphony Biosciences - LinkedIn
Symphony Biosciences | 261 followers on LinkedIn. Orchestrating the immune response against cancer through innovative biomaterials | Empower the immune system to fight cancer using innovative ...See details»
SYMPHONY BIOSCIENCES, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SYMPHONY BIOSCIENCES, INC. of Santa Monica, CA. Get the latest business insights from Dun & …See details»
Symphony Biosciences - Graduated Companies
Symphony Biosciences is orchestrating the immune response against cancer using innovative biomaterials. Market: Targeting solid tumors, Symphony's product presents a $1B+ market opportunity. Their first disease indication …See details»
Symphony Biosciences - Crunchbase
Symphony Biosciences empowers the immune system to fight cancer.See details»
Implantable polymer ‘sponge’ helps kill cancers
Jan 22, 2023 The team aims to make SymphNode available to treat human cancers in the future by licensing the technology to Symphony Biosciences, a company based at the California NanoSystems Institute’s Magnify start-up …See details»
Scientists Develop Tiny Implant That Helps Fight Cancer
Jan 9, 2023 The researchers plan on figuring out SymphNode’s efficacy in humans via Symphony Biosciences, a startup they founded on UCLA’s campus. Meanwhile, they’re …See details»
Implantable ‘Sponge’ Helps Kill Cancer - plasticstoday.com
Jan 10, 2023 The team aims to make SymphNode available to treat human cancers in the future by licensing the technology to Symphony Biosciences, a company based at the California …See details»
Implantable "sponge" fights off cancer in striking mouse study
Negin Majedi/Symphony Biosciences. The team tested the system in mice with breast cancer and melanoma, with impressive results across the board. The SymphNode shrank tumors in 80% …See details»
Chicago Symphony Orchestra Association gets $50 million gift
2 days ago The gift provides “vital” capital to reduce the the association’s debt over time and fund musician and staff retirement benefits, Chicago Symphony Orchestra tours, CSO music …See details»
Symphony Biosciences - Updates, News, Events, Signals & Triggers
Symphony Biosciences empowers the immune system to fight cancer.See details»
Chicago Symphony Orchestra Association Receives $50 Million Gift
2 days ago In Tuesday’s (12/10) Chicago Sun-Times, Stefano Esposito writes, “The Chicago Symphony Orchestration Association has received a $50 million gift from the Zell Family …See details»
Tiny Implantable Device Designed by UCLA Scientists Helps Kill …
Jan 10, 2023 Negin Majedi/Symphony Biosciences. The SymphNode device (left), contains nanoparticles (red dots) that release a drug that blocks the activity of regulatory T cells …See details»
Manassas Symphony Orchestra | Manassas VA - Facebook
Manassas Symphony Orchestra, Manassas, Virginia. 1,553 likes · 60 talking about this · 143 were here. Manassas Symphony Orchestra, winner of the 2019 Seefeldt Award and the 2015 …See details»
Chicago Symphony Orchestra Association receives $50 million …
2 days ago The Chicago Symphony Orchestra Association on Tuesday announced that it had received a donation of $50 million from benefactors Helen and Sam Zell on behalf of the Zell …See details»
2023-2024 Annual Report - harrisburgsymphony.org
2023-2024 Harrisburg Symphony Orchestra Meet the Orchestra The Harrisburg Symphony Association and Local 294 of the American Federation of Musicians are pleased to announce …See details»